title: Infection of elderly patients receiving high dose cytarabine-based chemotherapy for induction treatment of acute myelogenous leukemia (AML)
authors.forename: J
authors.initials: J
authors.lastname: Nemunaitis
authors.forename: W
authors.initials: W
authors.lastname: Meyer
authors.forename: J
authors.initials: J
authors.lastname: Nemunaitis
authors.forename: E
authors.initials: E
authors.lastname: Taylor
authors.forename: C
authors.initials: C
authors.lastname: Riley
authors.forename: B
authors.initials: B
authors.lastname: Cooper
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007239:Infections / Q000150:complications*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies
chemical_list: D003561:Cytarabine